{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-24-012340","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.073116+00:00","generated_at":"2026-05-31T21:10:32.983579+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alzamend Neuro announces 1-for-10 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective July 16, 2024; reduces outstanding shares from ~7.98M to ~798K.","Split aims to meet Nasdaq minimum bid price of $1.00 per share.","No fractional shares; cash payments for fractional shares via Computershare.","Authorized shares and par value ($0.0001) unchanged.","Stockholders authorized split range 1:2 to 1:20 in April; board set 1:10 in June."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-24-012340","json":"https://secwatch.observer/filing/0001214659-24-012340.json","markdown":"https://secwatch.observer/filing/0001214659-24-012340.md","text":"https://secwatch.observer/filing/0001214659-24-012340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/0001214659-24-012340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924012340/b7112428k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:10:32.983579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}